Connexion
E-mail
Mot de passe
Afficher le mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON

INNATE PHARMA

(IPH)
  Rapport
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFondsCommunauté 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur INNATE PHARMA
06/01Innate pharma obtains eur28.7m in non- dilutive financing in the form of state guarante..
05/01INNATE PHARMA : Obtains €28.7m in Non-Dilutive Financing in the Form of State Guaranteed L..
05/01Innate Secures 28.7 Million Euros in State-Guaranteed Loans
05/01Innate Pharma Receives $32.4 Million State-Backed Financing
05/01Innate Pharma S.A. Obtains €28.7 Million in Non-Dilutive Financing in the Form of ..
04/01INNATE PHARMA : to Participate in Upcoming Investor Conferences - Form 6-K
2021Innate Pharma - FIRST PATIENT DOSED IN IPH6101/SAR443579, PHASE 1/2 CLINICAL TRIAL IN V..
2021INNATE PHARMA : - Form 6-K
2021Innate Pharma Says Partner Sanofi Doses First Patient in Phase 1/2 In-Human Blood Cance..
2021Innate Pharma Sa Announces the First Patient Was Dosed in A Phase 1/2 Clinical Trial
2021Innate pharma - monalizumab combined with cetuximab and durvalumab demonstrates anti-tu..
2021Innate Pharma Says Cancer Drugs Combination Shows Anti-Tumor Activity
2021INNATE PHARMA : Monalizumab Combined With Cetuximab and Durvalumab Demonstrates Anti-Tumor..
2021Innate Pharma SA Announces That Data from the Phase 2 Expansion Cohort
2021INNATE PHARMA : to Present Monalizumab Data at ESMO Immuno-Oncology 2021 Congress - Form 6..
2021Innate Pharma SA to Present Monalizumab Data at ESMO Immuno-Oncology 2021 Congress
2021GLOBAL MARKETS LIVE : Valneva, Dell, HP, The Gap, Booking...
2021INNATE PHARMA : to Participate in the Evercore ISI 4th Annual HealthConX Virtual Conferenc..
2021INNATE PHARMA : Third Quarter 2021 Report - Form 6-K
2021Innate Pharma Highlights New NK Cell Engager Data With Partner Sanofi at SITC Annual Me..
2021Innate Pharma Announces Conference Call and Webcast for Q3 2021 Business Update - Form ..
2021Innate Pharma 2022 Financial Calendar - Form 6-K
2021TODAY ON WALL STREET : The list of worries grows for investors
2021ANALYST RECOMMENDATIONS : BHP, Lear, Naked Wines, Teradata, Visteon...
2021BOLSA DE MADRID : Asia en aguas turbulentas
2021NASDAQ 100 : Top Midday Gainers
2021Wall Street Futures in Holding Pattern Ahead of Fed Meeting Next Week
2021Top Premarket Gainers
2021INNATE PHARMA : Monalizumab Data from COAST Trial Presented at ESMO Congress 2021 (Form 6-..
2021INNATE PHARMA : Monalizumab Data from COAST Trial Presented at ESMO Congress 2021
2021GLOBAL MARKETS LIVE : Microsoft, Apple, The Boeing Company, AT&T, Activision Blizzard...
2021INNATE PHARMA : REPORTS FIRST HALF 2021 FINANCIAL RESULTS AND BUSINESS UPDATE (Form 6-K)
2021Innate Pharma Posts Wider H1 2021 Net Loss, Revenue Falls
2021INNATE PHARMA : Interim financial report 961.5 KB
2021INNATE PHARMA : Reports First Half 2021 Financial Results and Business Update
2021Innate Pharma S.A. Announces Management Changes
2021Innate Pharma S.A. Reports Earnings Results for the Half Year Ended June 30, 2021
2021Top Premarket Decliners
2021INNATE PHARMA S A : Top Brass to Offer H1 Business Update Next Week - Shares Drop in Pre-M..
2021INNATE PHARMA : Announces Conference Call and Webcast for First Half 2021 Business Update ..
2021INNATE PHARMA : Announces Conference Call and Webcast for First Half 2021 Business Update
2021INNATE PHARMA S A : Shares Jump After SVB Leerink Upgrades Rating to Outperform
2021INNATE PHARMA S A : Says AstraZeneca to Present Monalizumab Data at Oncology Conference; S..
2021GLOBAL MARKETS LIVE : Ford, Walmart, Apple, Volkswagen, Tesla...
2021INNATE PHARMA : AstraZeneca to present new data on monalizumab in combination with durvalu..
2021INNATE PHARMA : Monalizumab and ANKET™ Data Will be Presented at ESMO 2021 Virtual C..
2021GLOBAL MARKETS LIVE : Sanofi, Walt Disney, Roche, Flatexdegiro, KBC Group...
2021INNATE PHARMA : to Participate in Upcoming Investor Conferences (Form 6-K)
2021INNATE PHARMA : to Participate in Upcoming Investor Conferences
2021INNATE PHARMA : Corporate Presentation | July 2021
2021GLOBAL MARKETS LIVE : Facebook, AngloGold, Didi, Weibo, Daimler...
2021EN DIRECTO DESDE LOS MERCADOS : Welbilt, Google, Twitter, Alstom, AngloGold, Sicit, Volksw..
2021INNATE PHARMA : Update on Avdoralimab Phase 2 Force Trial in COVID-19 Patients With Severe..
2021INNATE PHARMA S A : Trial of Avdoralimab for COVID-19 Did Not Meet Goals; To Stop Explorat..
2021INNATE PHARMA : to Stop Evaluating Antibody for COVID-19 After Mid-Stage Failure
2021Update on Avdoralimab Phase 2 Force Trial in COVID-19 Patients With Severe Pneumonia
2021Innate Pharma SA Announces Update on Avdoralimab Phase 2 Force Trial in COVID-19 Patien..
2021RESULTS PRESENTED AT 16TH INTERNATIO : 00 p.m. CEST / 8:00 a.m. EDT (Form 6-K)
2021INNATE PHARMA : presents preliminary data from TELLOMAK trial showing clinical response fo..
2021Innate Pharma Presents Preliminary Data from TELLOMAK Trial Showing Clinical Response f..
2021GLOBAL MARKETS LIVE : Oracle, General Motors, Credit Suisse, Sony, Made.com...
2021INNATE PHARMA : Company to highlight lacutamab data in mycosis fungoides and share data on..
2021EN DIRECTO DESDE LOS MERCADOS : Solarpack, Oracle, Credit Suisse, EQT, eBay, Nintendo, Bla..
2021Innate Pharma to Host Virtual Investor Event to Highlight Progress Against Company Stra..
2021INNATE PHARMA : Presents New Data on Next-Generation NK Cell Engager Platform at FOCIS 202..
2021Innate Pharma Presents New Data on Next-Generation NK Cell Engager Platform at FOCIS 20..
2021Innate Pharma Molecule Shows Anti-Tumor Effect in Preclinical Studies
2021Innate Pharma Presents New Data on Next-Generation NK Cell Engager Platform at FOCIS 20..
2021INNATE PHARMA : New Lacutamab Data From Tellomak Trial to be Showcased in Oral Presentatio..
2021New Lacutamab Data from TELLOMAK Trial to be Showcased in Oral Presentation at Upcoming..
2021Innate Pharma S.A. Announces New Lacutamab Data from Tellomak Trial in Oral Presentatio..
2021INNATE PHARMA : Assemblee Generale Mixte
2021INNATE PHARMA : Outcome of Innate Pharma's Annual General Meeting (Form 6-K)
2021INNATE PHARMA : Outcome of Innate Pharma's Annual General Meeting
2021INNATE PHARMA : Outcome of Innate Pharma's Annual General Meeting
1  2  3  4  5  6  7  8  9Suiv.
Prochain événement sur INNATE PHARMA